Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine
- PMID: 32401410
- PMCID: PMC7261985
- DOI: 10.1111/dth.13565
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment on
-
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10. J Am Acad Dermatol. 2020. PMID: 32283237 Free PMC article. No abstract available.
Similar articles
-
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.J Allergy Clin Immunol Pract. 2020 Sep;8(8):2777-2779.e1. doi: 10.1016/j.jaip.2020.05.046. Epub 2020 Jun 7. J Allergy Clin Immunol Pract. 2020. PMID: 32525093 Free PMC article. No abstract available.
-
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.Dermatol Ther. 2020 May;33(3):e13380. doi: 10.1111/dth.13380. Epub 2020 Apr 16. Dermatol Ther. 2020. PMID: 32253799 Free PMC article. Review.
-
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.J Med Case Rep. 2020 Nov 3;14(1):210. doi: 10.1186/s13256-020-02504-8. J Med Case Rep. 2020. PMID: 33138853 Free PMC article.
-
Facts, not Fear: Safety of Hydroxychloroquine.Am J Med Sci. 2020 Aug;360(2):199-200. doi: 10.1016/j.amjms.2020.05.003. Epub 2020 May 11. Am J Med Sci. 2020. PMID: 32560964 No abstract available.
-
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.Dermatol Ther. 2018 Sep;31(5):e12660. doi: 10.1111/dth.12660. Epub 2018 Aug 28. Dermatol Ther. 2018. PMID: 30152569 Review.
Cited by
-
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.Dermatol Ther. 2021 Jan;34(1):e14662. doi: 10.1111/dth.14662. Epub 2020 Dec 26. Dermatol Ther. 2021. PMID: 33301232 Free PMC article.
-
Acute generalized exanthematous pustulosis: a complication of COVID-19 infection or therapy?J Cosmet Dermatol. 2022 May;21(5):1784-1787. doi: 10.1111/jocd.14930. Epub 2022 Apr 5. J Cosmet Dermatol. 2022. PMID: 35319163 Free PMC article. No abstract available.
-
Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration of CARD14 gene mutations.Front Med (Lausanne). 2023 Apr 6;10:1161837. doi: 10.3389/fmed.2023.1161837. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37089611 Free PMC article.
-
Generalized exanthema due to hydroxychloroquine during COVID-19 prophylaxis.Int J Clin Pract. 2021 Feb;75(2):e13793. doi: 10.1111/ijcp.13793. Int J Clin Pract. 2021. PMID: 33113232 Free PMC article. No abstract available.
-
A case of acute generalized exanthematous pustulosis following COVID-19 infection and remdesivir.Clin Case Rep. 2023 May 29;11(6):e7423. doi: 10.1002/ccr3.7423. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37261394 Free PMC article.
References
-
- World Health Organization . Coronavirus disease 2019 (COVID‐19) Situation Report—100. https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/2.... Accessed April 30, 2020.
-
- Observatoire National des Maladies Nouvelles et Émergentes . Note sur la situation épidémiologique du ‘COVID‐19’ à la date du 26 Avril 2020. http://www.onmne.tn/fr/images/COVID-19-dernier-bulletin.pdf. Accessed April 30, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources